NEO-811 Chicago Site is a clinical research site located in Zion, Illinois, United States 60099.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
NEO-811 Chicago Site has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma, RCC.
Sponsors: Neomorph, Inc.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Zion
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NEO-811 Chicago Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NEO-811 Chicago Site has 1 clinical trials on record, with 1 currently active. Their work covers Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma, RCC.
NEO-811 Chicago Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.